Acadian Asset Management’s Yarrow Bioscience YARW Stock Holding History

Acadian Asset Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Hold	7,636	–	–	﹤0.01%	1603
2026 Q1	$228K	Sell	7,636 -5,134	-40%	-$150K	﹤0.01%	1549
2025 Q4	$370K	Buy	12,770 +3,842	+43%	+$77.1K	﹤0.01%	1392
2025 Q3	$148K	Buy	8,928 +8,480	+1,893%	+$277K	﹤0.01%	1442
2025 Q2	$36K	Buy	+448	New	+$29.1K	﹤0.01%	1521
2020 Q2	–	Sell	-9	Closed	-$85K	–	2353
2020 Q1	$85K	Buy	9 +3	+50%	+$47.1K	﹤0.01%	1383
2019 Q4	$92K	Sell	6 -5	-45%	-$83.3K	﹤0.01%	1486
2019 Q3	$170K	Hold	11	–	–	﹤0.01%	1356
2019 Q2	$227K	Sell	11 -1	-8%	-$24.7K	﹤0.01%	1195
2019 Q1	$333K	Buy	12 +2	+20%	+$48K	﹤0.01%	1221
2018 Q4	$147K	Buy	+10	New	+$224K	﹤0.01%	1182

Other funds holding YARW

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $136M AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Acadian Asset Management's YARW Position: Q2 2026 in Review

Acadian Asset Management held its Yarrow Bioscience (YARW) position steady in Q2 2026 at 7,636 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Acadian Asset Management first reported a position in YARW in Q4 2018 and has held it in 11 quarters since. The position peaked at $370K in Q4 2025. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

Acadian Asset Management held 7,636 shares of Yarrow Bioscience worth $248K as of Q2 2026.
Acadian Asset Management left its Yarrow Bioscience share count unchanged in Q2 2026.
Yarrow Bioscience made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1603 holding.
Acadian Asset Management first reported a position in Yarrow Bioscience in Q4 2018 and has held it in 11 quarters since.
Acadian Asset Management's Yarrow Bioscience position peaked at $370K in Q4 2025.
40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.